This project has been flagged by a community member as inappropriate due to reason below.*

Survey

Slingshot members are conducting a survey! The topic is:

Quarterly Survey: Breast Implants April 2023

Ticker(s): JNJ, SIEN, ABBV

Who's being surveyed?

This survey includes 20 Plastic Surgeons.

Survey Questions
Q1.

How many breast implant procedures do you perform on average each month?

Q2.

How would you best describe your practice?

  • Community
  • Academic
  • Other

Q3.

How many patient breast implant procedures used the following manufacturers in the last 90 days:

  • Allergan:
  • Mentor:
  • Sientra:
  • Other:

Q4.

How many patient breast implant procedures do you expect to use each of the following in the next 90 days:

  • Allergan:
  • Mentor:
  • Sientra:
  • Other:

Q5.

What is the percentage breakdown of breast implant brands you use today? Please specify between 0-100 for each (sum to 100%)

  • Allergan:
  • Mentor:
  • Sientra:
  • Other:

Q6.

How do you expect your usage to change moving forward?

Q7.

Which breast implant manufacturer do you prefer? Select one.

  • Allergan:
  • Mentor:
  • Sientra:
  • Other:

Q8.

Please elaborate on your preference.

Q9.

How would your rate Allergen on the following (where 1 is low and 5 is high)?

  • Safety
  • Efficacy
  • Payor Access

Q10.

How would your rate Mentor on the following (where 1 is low and 5 is high)?

  • Safety
  • Efficacy
  • Payor Access

Q11.

How would your rate Sientra on the following (where 1 is low and 5 is high)?

  • Safety
  • Efficacy
  • Payor Access

Q12.

What features being added to future generation of breast implants would have you consider switching brands/manufacturers or significantly shifting share?

Q13.

What changes, if any, have you noticed with payor reimbursement and insurance for breast implants?

Q14.

What is the most exciting new treatment/device/area of development in your specialty?

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.